verified SJR 0,693 · Q2 • database Scopus / SJR & Web of Science indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q2 — Drug Discovery lock Subscription

Current Drug Targets

Current Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 123. It has a price of 1800 €. It has an SJR impact factor of 0,693 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,693.

ISSN: 1389-4501

Publisher: Bentham Science Publishers

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,693 Q2

H-index 123

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

1.800 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,693

H-index

123

Docs (year)

Docs 3y

346

Total refs

6893

Cites 3y

1164

Citable 3y

323

Cites/Doc 2y

2.39

Ref/Doc

99.9

Immediate OA

1800 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)

Vitamin D Insufficiency and Diabetes Risks

Computational Advances in Chronic Diseases Diagnostics and Therapy - II

Computational Advances in Chronic Diseases Diagnostics and Therapy - I

Combined Treatment Modalities for Age Related Macular Degeneration

Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration

Chloroquine Resistance Reversal Agents as Promising Antimalarial Drugs

Chitin-Related Enzymes in Agro-Biosciences

Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer

Chemokines in Rheumatic Diseases

Chemokines in Gastrointestinal Disorders

Chemokines as Potential Therapeutic Targets in Atherosclerosis

SHOW MORE ARTICLES

Chemokines and Their Receptors in Central Nervous System Disease

gamma-Secretase as a Therapeutic Target in Alzheimers Disease

Cervical Cancer: Are There Potential New Targets? An Update on Preclinical and Clinical Results

ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis

Atherosclerosis, Degenerative Aortic Stenosis and Statins

Aqueous Extracts of Selected Potentilla Species Modulate Biological Activity of Human Normal Colon Cells

ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease

Antioxidant Therapeutic Targets in COPD

Antifungal Susceptibility Testing Methods

Anti-IL-12/23 in Crohn's Disease: Bench and Bedside

Angiotensin Type 1 Receptor Blockers in Heart Failure

Alginate Bead-Encapsulated PEDF Induces Ectopic Bone Formation In Vivo in the Absence of Co-Administered Mesenchymal Stem Cells

FAQs

Current Drug Targets has an SJR of 0,693 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 1800 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Drug Targets is 24%.

Current Drug Targets

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Drug Targets?

What is the APC / publication cost?

What is the acceptance rate?